Sao Paulo-based Intermed makes ventilators and respirators for the hospital market in Latin America and Brazil.
"The acquisition of Intermed complements our global respiratory product platform and advances our strategy to expand outside of the U.S. through investments that build scale and local capabilities in high-value markets," CareFusion chairman & CEO Kieran Gallahue said in prepared remarks. "Intermed brings a strong distributor network, local manufacturing capabilities and a new product portfolio that we believe can serve as a base for CareFusion to continue our global expansion efforts in Latin America."
CareFusion said the deal, expected to close during its fiscal 2nd quarter ending Dec. 31, is part of its strategy to "deploy capital to accelerate long-term growth." The company had $1.44 billion in cash and equivalents as of March 31, according to a regulatory filing.
Intermed is expected to add about $25 million to CareFusion’s top line each year.